AU2002337388A1 - Improvements in or relating to inhibition of viruses - Google Patents

Improvements in or relating to inhibition of viruses

Info

Publication number
AU2002337388A1
AU2002337388A1 AU2002337388A AU2002337388A AU2002337388A1 AU 2002337388 A1 AU2002337388 A1 AU 2002337388A1 AU 2002337388 A AU2002337388 A AU 2002337388A AU 2002337388 A AU2002337388 A AU 2002337388A AU 2002337388 A1 AU2002337388 A1 AU 2002337388A1
Authority
AU
Australia
Prior art keywords
viruses
inhibition
relating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002337388A
Other languages
English (en)
Inventor
Jamie Arnold
Jan Balzarini
Daniel Brown
Craig Cameron
Christian Castro
Jason Graci
Victoria Korneeva
David Loakes
Kei Moriyama
Kazuo Negishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0126701A external-priority patent/GB0126701D0/en
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of AU2002337388A1 publication Critical patent/AU2002337388A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2002337388A 2001-11-07 2002-11-07 Improvements in or relating to inhibition of viruses Abandoned AU2002337388A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0126701A GB0126701D0 (en) 2001-11-07 2001-11-07 Improvements in or relating to induction of mutations in viruses
GB0126701.2 2001-11-07
US10/207,005 2002-07-30
US10/207,005 US7049303B2 (en) 2001-11-07 2002-07-30 Inhibition of viruses
PCT/GB2002/005031 WO2003039450A2 (en) 2001-11-07 2002-11-07 Improvements in or relating to inhibition of viruses

Publications (1)

Publication Number Publication Date
AU2002337388A1 true AU2002337388A1 (en) 2003-05-19

Family

ID=26246745

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002337388A Abandoned AU2002337388A1 (en) 2001-11-07 2002-11-07 Improvements in or relating to inhibition of viruses

Country Status (5)

Country Link
US (2) US7049303B2 (cg-RX-API-DMAC10.html)
EP (1) EP1441744A2 (cg-RX-API-DMAC10.html)
JP (1) JP2005507944A (cg-RX-API-DMAC10.html)
AU (1) AU2002337388A1 (cg-RX-API-DMAC10.html)
WO (1) WO2003039450A2 (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200418498A (en) * 2002-09-30 2004-10-01 Genelabs Tech Inc Nucleoside derivatives for treating hepatitis C virus infection
US7094768B2 (en) * 2002-09-30 2006-08-22 Genelabs Technologies, Inc. Nucleoside derivatives for treating hepatitis C virus infection
US7169918B2 (en) * 2003-10-27 2007-01-30 Genelabs Technologies, Inc. Methods for preparing 7-(2′-substituted-β-D-ribofuranosyl)-4-(NR2R3)-5-(substituted ethyn-1-yl)-pyrrolo[2,3-d]pyrimidine derivatives
MXPA06014909A (es) 2004-06-18 2007-02-28 Chiron Corp Derivados de n-(1-(1-bencil -4-fenil-1h -imidazol -2-il)-2, 2-dimetilpropil) benzamida y compuestos relacionados como inhibidores de proteina de huso de cinesina (ksp) para el tratamiento del cancer.
AU2006222563A1 (en) * 2005-03-08 2006-09-14 Biota Scientific Management Pty Ltd. Bicyclic nucleosides and nucleotides as therapeutic agents
EP3042660A3 (en) * 2008-04-15 2016-10-26 RFS Pharma, LLC. Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
JP5719840B2 (ja) * 2009-06-08 2015-05-20 武田薬品工業株式会社 Ｊａｋの阻害剤としてのジヒドロピロロナフチリジノン化合物
US9809616B2 (en) 2012-10-29 2017-11-07 Emory University Pyrimidine nucleosides and their monophosphate prodrugs for the treatment of viral infections and cancer
WO2016106050A1 (en) 2014-12-26 2016-06-30 Emory University N4-hydroxycytidine and derivatives and anti-viral uses related thereto
RU2020116571A (ru) 2017-12-07 2021-11-22 Эмори Юниверсити N4-гидроксицитидин и производные и связанные с этим противовирусные применения
WO2023152709A1 (en) * 2022-02-14 2023-08-17 Arbutus Biopharma Corporation Rna polymerase inhibitors and methods using same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8802687D0 (sv) 1988-07-20 1988-07-20 Astra Ab Nucleoside derivatives
WO1990006319A1 (en) 1988-12-05 1990-06-14 Schering Corporation Antiviral dimers and trimers
DK62592D0 (cg-RX-API-DMAC10.html) * 1992-05-14 1992-05-14 Novo Nordisk As
US5773424A (en) 1994-12-16 1998-06-30 Research Corporation Technologies, Inc. Treatment of toxoplasmosis
ES2276404T3 (es) 1995-06-07 2007-06-16 Emory University Nucleosidos con actividad antivirus de la hepatitis-b.
AU727177B2 (en) 1996-10-16 2000-12-07 Icn Pharmaceuticals, Inc. Purine L-nucleosides, analogs and uses thereof
NZ507848A (en) * 1996-10-28 2005-01-28 Univ Washington Method of increasing the mutation rate of a virus in a non-human by administering an RNA nucleoside analogue to a virally infected cell
EA200700564A1 (ru) 1998-02-25 2007-08-31 Эмори Юниверсити 2`-фторнуклеозиды
IL133680A0 (en) 1999-09-10 2001-04-30 Can Fite Technologies Ltd Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
JP2003524636A (ja) 1999-12-22 2003-08-19 インスパイアー ファーマシューティカルズ，インコーポレイティド プリン性受容体アゴニストによる胃腸管の処置方法

Also Published As

Publication number Publication date
WO2003039450A3 (en) 2003-08-21
US7049303B2 (en) 2006-05-23
US20030130226A1 (en) 2003-07-10
US20050043268A1 (en) 2005-02-24
WO2003039450A2 (en) 2003-05-15
EP1441744A2 (en) 2004-08-04
JP2005507944A (ja) 2005-03-24

Similar Documents

Publication Publication Date Title
AU2002237124B2 (en) Compositions and methods relating to osteoarthritis
HUP0500042A3 (en) Use of hmg fragments as anti-inflammatory agents
GB0107669D0 (en) Improvements relating to liver surgery
AU2001234837A1 (en) Azapeptides useful in the treatment of hepatitis c
AU2001227972A1 (en) Methods to treat alpha-1-antitrypsin deficiency
AU2001260834A1 (en) The treatment of herpes
AU2001293048A1 (en) Antiviral compositions and methods of use
GB2373004B (en) Improvements in or relating to the protection of buildings
AU2002359792A1 (en) Methods and compositions for the inhibition of viral release
EP1439845A4 (en) INACTIVATION OF THE PAPILLOMA
WO2002083858A8 (en) Methods to inhibit viral replication
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
GB0100151D0 (en) Methods of sputtering
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2002236439A1 (en) Purification of argon
AU2002323085A1 (en) Inhibition of viral replication by targeting rna-dna complexes
GB0118126D0 (en) Improvements in or relating to vapourisers
AU2002321556A1 (en) Inhibition of replication factor c
AUPR528501A0 (en) Improvements in or relating to shelving
AU2002334068A1 (en) Improvements in or relating to detection of impaired fertility
HK1063638A (en) Methods to inhibit viral replication
GB0101480D0 (en) Improvements and or relating to organic compositions
GB0122499D0 (en) Improvements in or relating to the removal of chemicals
AU2002307237A1 (en) Carboxybenzopyran derivatives and compositions
AU2002231976A1 (en) Improvements relating to the protection of buildings

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase